Axel Walther - Concepedia

Author

Axel Walther

University Hospitals Bristol NHS Foundation Trust ORCID

Also Known As

A Montes, A Walther, A. Walther, A.W. Walther, Andrew J. Walther, Andrew Weaver, Antonia Walther, Axel Walther, Carlton Victoria EH, Christopher G Smith

126

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

University Hospitals Bristol NHS Foundation Trust Cancer Research UK University College London University of Birmingham Institute of Cancer Research

About

Axel Walther is an author at University Hospitals Bristol NHS Foundation Trust specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.3K
2	Management	2	2	32
3	Business	1	1	18
4	Education	1	1	18
5	Health Sciences	1	1	11

Axel Walther

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3 Ian PM Tomlinson, Emily L. Webb, Luis G. Carvajal‐Carmona, Nature Genetics Cancer SusceptibilityGenome-wide Association StudyChromosomes 10P14MedicineGenetics	2008	561
Chromosomal Instability Confers Intrinsic Multidrug Resistance Alvin Lee, David Endesfelder, Andrew J. Rowan, Cancer Research	2011	477
Copy number signatures and mutational processes in ovarian carcinoma Geoff Macintyre, Teodora Goranova, Dilrini De Silva, Nature Genetics Somatic VariantTumor HeterogeneityPathologyOvarian CancerCopy Number Signatures	2018	433
Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk Emma Jaeger, Emily L. Webb, Kimberley Howarth, Nature Genetics Cancer RiskChromosome 15Q13.3MedicineGeneticsGenetic Epidemiology	2007	303
Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals Malcolm G. Dunlop, Albert Tenesa, Susan M. Farrington, Gut	2012	137
Safety and efficacy of adoptive cell transfer using autologous tumor infiltrating lymphocytes (LN-145) for treatment of recurrent, metastatic, or persistent cervical carcinoma. Amir A. Jazaeri, Emese Zsíros, Rodabe N. Amaria, Journal of Clinical Oncology Cell TherapySurgical OncologyCancer ManagementImmunologyAutologous Tumor	2019	131
Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer James Yarmolinsky, Caroline J. Bull, Emma E. Vincent, JAMA	2020	129
British Gynaecological Cancer Society (BGCS) uterine cancer guidelines: Recommendations for practice Jo Morrison, Janos Balega, Lynn Buckley, European Journal of Obstetrics & Gynecology and Reproductive Biology UrologyGynecological SurgeryMedicineGynecologyUterine Cancer Guidelines	2021	109
Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis James Yarmolinsky, Caroline L. Relton, Artitaya Lophatananon, PLoS Medicine	2019	106
Copy-number signatures and mutational processes in ovarian carcinoma Geoff Macintyre, Teodora Goranova, Dilrini De Silva, OncologySomatic VariantTumor HeterogeneityCopy-number SignaturesGenetics	2017	94

Page 1